Kinsale Capital/$KNSL
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Kinsale Capital
Kinsale Capital Group Inc is an insurance holding company. The company is engaged in offering property, casualty, and specialty insurance products. It offers specialty insurance products for allied health, healthcare, life sciences, professional, and a public entity. The company operates in only one reportable segment which is the Excess and Surplus Lines Insurance segment, which includes commercial excess and surplus lines liability and property insurance products through its underwriting divisions. The company generates revenues in the form of premiums and investment income.
- Ticker
- $KNSL
- Sector
- Finance
- Primary listing
- NYSE
- Employees
- 716
- Headquarters
- Richmond, United States
- Website
- www.kinsalecapitalgroup.com
Kinsale Capital Metrics
BasicAdvanced
$8.6B
15.29
$24.64
0.90
$0.92
0.27%
Price and volume
Market cap
$8.6B
Beta
0.9
52-week high
$462.82
52-week low
$287.20
Average daily volume
217K
Dividend rate
$0.92
Financial strength
Current ratio
0.194
Quick ratio
0.086
Long term debt to equity
0.11
Total debt to equity
0.11
Dividend payout ratio (TTM)
3.40%
Interest coverage (TTM)
60.23%
Profitability
EBITDA (TTM)
732.259
Gross margin (TTM)
31.14%
Net profit margin (TTM)
28.49%
Operating margin (TTM)
36.33%
Effective tax rate (TTM)
20.26%
Revenue per employee (TTM)
$2,790,000
Management effectiveness
Return on assets (TTM)
7.56%
Return on equity (TTM)
30.27%
Valuation
Price to earnings (TTM)
15.287
Price to revenue (TTM)
4.338
Price to book
4.22
Price to tangible book (TTM)
4.22
Price to free cash flow (TTM)
8.653
Free cash flow yield (TTM)
11.56%
Free cash flow per share (TTM)
43.535
Dividend yield (TTM)
0.24%
Forward dividend yield
0.27%
Growth
Revenue change (TTM)
15.82%
Earnings per share change (TTM)
28.61%
3-year revenue growth (CAGR)
24.71%
10-year revenue growth (CAGR)
33.55%
3-year earnings per share growth (CAGR)
35.74%
10-year earnings per share growth (CAGR)
45.37%
3-year dividend per share growth (CAGR)
15.87%
What the Analysts think about Kinsale Capital
Analyst ratings (Buy, Hold, Sell) for Kinsale Capital stock.
Analyst projections of the future price of Kinsale Capital stock.
Bulls say / Bears say
Kinsale earned $175.9 million in Q2 2026, up 31.1% year on year, and its combined ratio was a strong 75.5%. That profitability gives it room to stay selective when rivals compete aggressively. (Kinsale Capital)
Net investment income rose 19.9% to $55.7 million in Q2, supported by growth in the investment portfolio. This provides a growing earnings stream alongside underwriting. (Kinsale Capital)
Despite weakness in commercial property, gross written premiums outside that division grew 4.8% in the first half. Management also reported stronger submissions and broker activity in its small and medium-sized business focus, offering other avenues for growth. (Kinsale Capital, Exa.ai)
Gross written premiums fell 5% in Q2, with commercial property premiums down 32.7% amid intense competition. Kinsale is choosing not to chase poorly priced business, but that discipline is slowing top-line growth. (Kinsale Capital)
Competition is spreading beyond property: management cited greater pressure in construction and some casualty lines, while the company’s combined pricing trend reflected a 5.9% market decline in Q2. If soft pricing persists, it could constrain growth and weaken future underwriting margins. (Exa.ai)
Kinsale’s shares trade at about 3.8 times book value, versus roughly 1.4 times for the property-and-casualty industry, according to a recent report. That valuation leaves less room for disappointment if premium growth stays weak or profitability normalises. (Yahoo Finance)
Data summarised monthly by Lightyear AI. Last updated on 1 Oct 2026.
Kinsale Capital Financial Performance
Revenues and expenses
Kinsale Capital Earnings Performance
Company profitability
Upcoming events
No upcoming events
Kinsale Capital News
AllArticlesVideos
Funds containing Kinsale Capital
AllUSDEURGBP
Fund name | Fund size | $KNSL weighting |
|---|---|---|
SPDR S&P 400 US Mid Cap£SPX4 | $6.4B | 0.24% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.24% |
iShares MSCI USA Small Cap CTB Enhanced ESG£CUS1 | $3.2B | 0.13% |
iShares MSCI USA Small Cap ESG Enhanced CTB€SXRG | $3.2B | 0.13% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.08% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.